Longboard Pharmaceuticals (LBPH) News Today $59.77 -0.07 (-0.12%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Braun Stacey Associates Inc. Takes Position in Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH)Braun Stacey Associates Inc. acquired a new stake in Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH - Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 299,156 shares of the company's stockNovember 18 at 7:28 AM | marketbeat.comHold Rating for Longboard Pharmaceuticals Amidst Acquisition Uncertainty and Speculative RisksNovember 13, 2024 | markets.businessinsider.comLongboard Pharmaceuticals Initiates Phase 3 DEEp OCEAN Study Evaluating Bexicaserin in Developmental and Epileptic Encephalopathies (DEEs)November 12, 2024 | finance.yahoo.comLongboard Pharmaceuticals Advances Neurological TreatmentsNovember 9, 2024 | markets.businessinsider.comLongboard Pharmaceuticals HSR waiting period expires for Lundbeck dealNovember 7, 2024 | msn.comLongboard Pharmaceuticals granted Orphan Drug Designation for bexicaserinNovember 5, 2024 | markets.businessinsider.comEmerald Advisers LLC Grows Position in Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH)Emerald Advisers LLC raised its holdings in Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH - Free Report) by 199.2% in the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 683,642 shares of the company's stock after acquiring an additional 455,119 shaNovember 3, 2024 | marketbeat.comLongboard Pharmaceuticals Inc options imply 0.8% move in share price post-earningsNovember 1, 2024 | markets.businessinsider.comLongboard Pharmaceuticals (NASDAQ:LBPH) Reaches New 1-Year High - Here's What HappenedLongboard Pharmaceuticals (NASDAQ:LBPH) Sets New 52-Week High - Time to Buy?November 1, 2024 | marketbeat.comLONGBOARD PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Longboard Pharmaceuticals, Inc. - LBPHOctober 31, 2024 | businesswire.comLongboard Pharmaceuticals, Inc. (NASDAQ:LBPH) Given Consensus Rating of "Hold" by AnalystsShares of Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH - Get Free Report) have received a consensus rating of "Hold" from the nine ratings firms that are covering the company, MarketBeat.com reports. Five investment analysts have rated the stock with a hold recommendation and four have issued a buOctober 28, 2024 | marketbeat.comLongboard Pharmaceuticals (NASDAQ:LBPH) Sets New 12-Month High - Here's What HappenedLongboard Pharmaceuticals (NASDAQ:LBPH) Sets New 52-Week High - Should You Buy?October 23, 2024 | marketbeat.comLongboard Pharmaceuticals (NASDAQ:LBPH) Sees Unusually-High Trading Volume - Should You Buy?Longboard Pharmaceuticals (NASDAQ:LBPH) Sees Strong Trading Volume - What's Next?October 21, 2024 | marketbeat.comSG Americas Securities LLC Buys Shares of 10,514 Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH)SG Americas Securities LLC bought a new stake in Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH - Free Report) during the third quarter, according to the company in its most recent disclosure with the SEC. The firm bought 10,514 shares of the company's stock, valued at approximately $350,000. Other lOctober 19, 2024 | marketbeat.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LBPH and ARC on Behalf of ShareholdersOctober 17, 2024 | globenewswire.comHC Wainwright & Co. Downgrades Longboard Pharmaceuticals (LBPH)October 17, 2024 | msn.comRandall Kaye Sells 16,667 Shares of Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) StockOctober 17, 2024 | insidertrades.comStrong Valuation and Strategic Acquisition Drive Buy Rating for Longboard PharmaceuticalsOctober 16, 2024 | markets.businessinsider.comTruist Securities Downgrades Longboard Pharmaceuticals (LBPH)October 16, 2024 | msn.comSTOCKHOLDER INVESTIGATION: The M&A Class Action Firm Investigates the Merger of Longboard Pharmaceuticals, Inc. – LBPHOctober 16, 2024 | globenewswire.comWedbush Lowers Longboard Pharmaceuticals (NASDAQ:LBPH) to HoldWedbush downgraded Longboard Pharmaceuticals from a "strong-buy" rating to a "hold" rating in a research report on Monday.October 16, 2024 | marketbeat.comLONGBOARD PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Longboard Pharmaceuticals, Inc. - LBPHOctober 15, 2024 | businesswire.comLongboard Pharmaceuticals, Inc. (NASDAQ:LBPH) Short Interest UpdateLongboard Pharmaceuticals, Inc. (NASDAQ:LBPH - Get Free Report) was the recipient of a large growth in short interest during the month of September. As of September 30th, there was short interest totalling 5,380,000 shares, a growth of 33.5% from the September 15th total of 4,030,000 shares. Currently, 16.0% of the company's shares are short sold. Based on an average trading volume of 655,600 shares, the days-to-cover ratio is presently 8.2 days.October 15, 2024 | marketbeat.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LBPH and OB on Behalf of ShareholdersOctober 15, 2024 | globenewswire.comSTOCKHOLDER INVESTIGATION: The M&A Class Action Firm Investigates the Merger of Longboard Pharmaceuticals, Inc. - LBPHOctober 15, 2024 | prnewswire.comLongboard Pharmaceuticals (NASDAQ:LBPH) Sees Large Volume Increase - Here's WhyLongboard Pharmaceuticals (NASDAQ:LBPH) Sees Unusually-High Trading Volume - Still a Buy?October 15, 2024 | marketbeat.comLongboard Pharmaceuticals (NASDAQ:LBPH) Given Neutral Rating at HC WainwrightHC Wainwright reaffirmed a "neutral" rating and set a $60.00 price target (down previously from $80.00) on shares of Longboard Pharmaceuticals in a research report on Tuesday.October 15, 2024 | marketbeat.comLongboard Pharmaceuticals Strikes $2.6 Billion Deal to Be Acquired by LundbeckOctober 14, 2024 | msn.comLundbeck to acquire Longboard Pharmaceuticals in $2.6B dealOctober 14, 2024 | finance.yahoo.comM&A News: Lundbeck to Acquire Longboard (NASDAQ:LBPH) for $2.6BOctober 14, 2024 | msn.comALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Longboard Pharmaceuticals, Inc.October 14, 2024 | prnewswire.comLongboard Pharmaceuticals Target of Unusually High Options Trading (NASDAQ:LBPH)Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH - Get Free Report) saw unusually large options trading on Monday. Traders bought 4,265 call options on the company. This represents an increase of 1,960% compared to the average volume of 207 call options.October 14, 2024 | marketbeat.comLongboard Pharmaceuticals (NASDAQ:LBPH) Earns Neutral Rating from B. RileyB. Riley restated a "neutral" rating and set a $60.00 price objective (up from $45.00) on shares of Longboard Pharmaceuticals in a research report on Monday.October 14, 2024 | marketbeat.comLongboard Pharmaceutical Stock Soars 51%. It's Being Bought for $2.6 Billion.October 14, 2024 | barrons.comShareholder Alert: Ademi LLP Investigates Whether Longboard Pharmaceuticals, Inc. Is Obtaining a Fair Price for Its Public ShareholdersOctober 14, 2024 | businesswire.comLBPH Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Longboard Pharmaceuticals, Inc. Is Fair to ShareholdersOctober 14, 2024 | businesswire.comLundbeck to Acquire Longboard Pharmaceuticals in a Strategic Deal, Significantly Enhancing Its Neuroscience PipelineOctober 14, 2024 | businesswire.comLongboard Pharmaceuticals (NASDAQ:LBPH) Shares Up 4.3% - Time to Buy?Longboard Pharmaceuticals (NASDAQ:LBPH) Shares Up 4.3% - What's Next?October 10, 2024 | marketbeat.comLongboard Pharmaceuticals Inc (LBPH) Q2 2024 Earnings Call Highlights: Promising Clinical ...October 9, 2024 | finance.yahoo.comQ2 2024 Longboard Pharmaceuticals Inc Earnings Call and Discussion of Topline Phase 1 SAD DataOctober 9, 2024 | gurufocus.comThe Manufacturers Life Insurance Company Increases Stock Position in Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH)The Manufacturers Life Insurance Company increased its position in Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH - Free Report) by 40.2% in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 117,739 shares of the compaOctober 9, 2024 | marketbeat.comLongboard Pharmaceuticals (NASDAQ:LBPH) Shares Gap Up - Should You Buy?Longboard Pharmaceuticals (NASDAQ:LBPH) Shares Gap Up - Here's WhyOctober 8, 2024 | marketbeat.comLongboard Pharmaceuticals (NASDAQ:LBPH) Stock Price Down 6.2% - Here's WhyLongboard Pharmaceuticals (NASDAQ:LBPH) Shares Down 6.2% - Here's WhyOctober 7, 2024 | marketbeat.comLongboard Pharmaceuticals (NASDAQ:LBPH) Stock Quotes, Forecast and News SummaryOctober 5, 2024 | benzinga.comLongboard Pharmaceuticals, Inc. (NASDAQ:LBPH) Receives Consensus Recommendation of "Buy" from AnalystsLongboard Pharmaceuticals, Inc. (NASDAQ:LBPH - Get Free Report) has been given a consensus rating of "Buy" by the nine research firms that are presently covering the company, MarketBeat reports. Nine research analysts have rated the stock with a buy recommendation. The average 12-month price targeOctober 3, 2024 | marketbeat.comLongboard Pharmaceuticals (NASDAQ:LBPH) Stock Price Up 4.3%Longboard Pharmaceuticals (NASDAQ:LBPH) Trading Up 4.3%October 1, 2024 | marketbeat.comDriehaus Capital Management LLC Has $13.21 Million Holdings in Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH)Driehaus Capital Management LLC raised its stake in Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH - Free Report) by 25.8% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 488,793 shares of the company's stock aSeptember 29, 2024 | marketbeat.comLongboard Pharmaceuticals begins Phase III Dravet syndrome trialSeptember 28, 2024 | finance.yahoo.comLynx1 Capital Management LP Purchases Shares of 167,317 Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH)Lynx1 Capital Management LP bought a new stake in Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH - Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 167,317 shares of the company's stock, valued at approximately $4,523,000. LongbSeptember 27, 2024 | marketbeat.comLongboard Pharmaceuticals Initiates Phase 3 DEEp SEA Study Evaluating Bexicaserin in Dravet SyndromeSeptember 26, 2024 | finance.yahoo.com Get Longboard Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for LBPH and its competitors with MarketBeat's FREE daily newsletter. Email Address Tesla Execs are Freaking Out (Ad)It’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands on it. And Elon Musk has completely restructured Tesla to chase this opportunity. This is a once-in-a-lifetime opportunity that you don’t want to miss. Click here to get the details. LBPH Media Mentions By Week LBPH Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LBPH News Sentiment▼0.520.46▲Average Medical News Sentiment LBPH News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LBPH Articles This Week▼14▲LBPH Articles Average Week Get Longboard Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for LBPH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies CRBP News Today QGEN News Today ITCI News Today ROIV News Today ASND News Today LEGN News Today ELAN News Today CYTK News Today BPMC News Today NUVL News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LBPH) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Longboard Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Longboard Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
